Viral Hepatitis
📧 Sign up to get email alerts when something new happens for Viral Hepatitis.
Sign up freeTop drugs studied for this disease
-
EMA guidance · 2014-07-25World Hepatitis Day – European Medicines Agency uses regulatory tools to facilitate patient access to innovative medicines
EMA highlights use of regulatory tools to improve timely patient access to innovative medicines for hepatitis on World Hepatitis Day.
-
EMA guidance · 2013-11-22European Medicines Agency advises on compassionate use of daclatasvir
The European Medicines Agency provides guidance on compassionate use of the antiviral daclatasvir, outlining conditions and considerations f…
-
EMA guidance · 2013-10-25European Medicines Agency advises on compassionate use of sofosbuvir
EMA provides guidance on compassionate use of sofosbuvir, outlining how it can be accessed in certain circumstances outside of approved indi…
-
EMA guidance · 2013-07-26World Hepatitis Day: 28 July 2013
Official EMA communication marking World Hepatitis Day (July 28, 2013) to raise awareness about hepatitis and the importance of prevention, …
-
EMA guidance · 2012-07-27World Hepatitis Day: 28 July 2012
EMA update highlighting World Hepatitis Day on 28 July 2012, focusing on awareness and public health messaging about hepatitis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.